Logo Image
|Articles|February 19, 2016

Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach

Author(s)DIA

How New Liberal Government Could Impact Health Care in Canada

After ten years of successive minority and/or majority Conservative leadership, Canada is now led by Prime Minister Justin Trudeau’s Liberal majority. A key component of the Liberal platform is the creation of a Chief Science Officer position to ensure that “scientific analyses are considered when the government makes decisions”; this renewed focus on evidence-based policy may be helpful to science-based industries across a number of sectors.

Read the article here. 

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Fayuvi
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Read more
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Addressing MFN Innovation Concerns
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
Read more